Analysts are smiling on Q&M Dental and keeping a positive outlook on the stock following its strong 1QFY2021 ended March and its robust Covid-19 testing business.
On May 18, Q&M announced that its 51%-owned subsidiary Acumen was awarded a tender by the Health Promotion Board (HPB) for the provision of Covid-19 swab and testing services. It will be a panel service provider of the HPB in respect of the Covid-19 swab and testing services.
Following this news, shares in surged some 3.6% when the market opened to 72 cents.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)